| John Roll, APRN,CNS | |
|
1000 Highway 12, Hettinger, ND 58639-7530 | |
| (701) 567-4561 | |
| Not Available |
| Full Name | John Roll |
|---|---|
| Gender | Male |
| Speciality | Clinical Nurse Specialist - Adult Health |
| Location | 1000 Highway 12, Hettinger, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487022885 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | R36407 (North Dakota) | Primary |
| Entity Name | West River Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174606271 PECOS PAC ID: 0042127045 Enrollment ID: O20040128001023 |
News Archive
Levels of galectin-3 are elevated in patients with pulmonary arterial hypertension and correlate with disease severity, research shows.
Researchers at Dana-Farber Cancer Institute have shown that several, rather than just one, cell-growth switches are simultaneously overactive in many brain tumors and other solid tumors, explaining why treatment with just a single "targeted" switch-blocking drug often yields disappointing results.
The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.
SARS-CoV-2, the virus that causes COVID-19, blocks the processes of innate immune activation that normally direct the production and/or signaling of type I interferon (IFN-I) by the infected cell and tissues.
After four patients contracted Legionnaires' disease at New York-Presbyterian Hospital, the state Health Department says appropriate steps have been taken to safeguard patients and staff from an outbreak of the disease.
› Verified 8 days ago
| Entity Name | West River Health Services |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1588763247 PECOS PAC ID: 0042127045 Enrollment ID: O20100909000218 |
News Archive
Levels of galectin-3 are elevated in patients with pulmonary arterial hypertension and correlate with disease severity, research shows.
Researchers at Dana-Farber Cancer Institute have shown that several, rather than just one, cell-growth switches are simultaneously overactive in many brain tumors and other solid tumors, explaining why treatment with just a single "targeted" switch-blocking drug often yields disappointing results.
The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.
SARS-CoV-2, the virus that causes COVID-19, blocks the processes of innate immune activation that normally direct the production and/or signaling of type I interferon (IFN-I) by the infected cell and tissues.
After four patients contracted Legionnaires' disease at New York-Presbyterian Hospital, the state Health Department says appropriate steps have been taken to safeguard patients and staff from an outbreak of the disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Roll, APRN,CNS Po Box 2010, Fargo, ND 58122-2484 Ph: (701) 234-2000 | John Roll, APRN,CNS 1000 Highway 12, Hettinger, ND 58639-7530 Ph: (701) 567-4561 |
News Archive
Levels of galectin-3 are elevated in patients with pulmonary arterial hypertension and correlate with disease severity, research shows.
Researchers at Dana-Farber Cancer Institute have shown that several, rather than just one, cell-growth switches are simultaneously overactive in many brain tumors and other solid tumors, explaining why treatment with just a single "targeted" switch-blocking drug often yields disappointing results.
The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.
SARS-CoV-2, the virus that causes COVID-19, blocks the processes of innate immune activation that normally direct the production and/or signaling of type I interferon (IFN-I) by the infected cell and tissues.
After four patients contracted Legionnaires' disease at New York-Presbyterian Hospital, the state Health Department says appropriate steps have been taken to safeguard patients and staff from an outbreak of the disease.
› Verified 8 days ago